Chimerix, Inc. (CMRX), the stock in the Medical Products industry could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CMRX’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Chimerix could be a solid choice for investors.
Current Quarter Estimates for CMRX
In the past 30 days, 1 estimate has gone higher for Chimerix. The trend has been pretty favorable too, with estimates of loss narrowing from 35 cents a share 30 days ago to a loss of 33 cents today, a move of 5.7%.
Current Year Estimates for CMRX
Meanwhile, Chimerix’s current year figures are also looking quite promising, with 2 estimates moving higher in the past month. The consensus estimate trend has also seen a boost for this time frame, with consensus estimate of loss narrowing from $1.85 per share 30 days ago to $1.65 per share today, a move of 10.8%.
Bottom Line
The stock has also started to move higher lately, adding 12% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment